📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial. (2019)

First Author: Al-Chalabi A

Attributed to: STRENGTH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2018-320288

PubMed Identifier: 31315908

Publication URI: http://europepmc.org/abstract/MED/31315908

Type: Journal Article/Review

Volume: 90

Parent Publication: Journal of neurology, neurosurgery, and psychiatry

Issue: 10

ISSN: 0022-3050